This product uses a proprietary purification process with a purity of up to 99.9%, and the content of heavy metals and impurities is far lower than industry standards, solving the pain point that ordinary industrial grade ethylene urea has excessive impurities and cannot be used for pharmaceutical synthesis. Its colorless crystalline form is easy to dissolve and process, can accurately participate in drug synthesis reactions, improve product yield and purity, and has good chemical stability, will not deteriorate during storage and transportation, ensuring batch stability of pharmaceutical production.
It appears as colorless crystalline solid with a purity of no less than 99.9%, heavy metal content ≤10ppm, loss on drying ≤0.1%, and ignition residue ≤0.05%. It is packaged in 5kg sealed glass bottles, stored in a dry environment filled with nitrogen to avoid light and high temperature, with a 24-month shelf life, and third-party inspection reports are provided for each batch.
It is mainly used for synthesizing imidazole anti-inflammatory drugs, anti-tumor adjuvant drugs and other pharmaceutical intermediates containing imidazolidinone structures, adapting to pharmaceutical research laboratories and large-scale production of large pharmaceutical factories. It is a high-end raw material choice in the pharmaceutical and chemical industry, meeting the compliance requirements of the global pharmaceutical industry.
Post RFQ
Chat
ALL CATEGORIES